Patents by Inventor Philippe Vayron

Philippe Vayron has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9499507
    Abstract: The invention relates to a method for preparing 5-amino-benzoyl-benzofuran derivatives having the general formula in which R1 is hydrogen or an alkyl or aryl group and R2 is hydrogen, an alkyl, alkoxy or dialkylaminoalkoxy group. According to the invention, the compounds having formula I are prepared by hydrogenating a 5-nitro-benzofuran derivative having the general formula in which R1 and R2 have the same meaning as above in the presence of palladized charcoal as a catalyst and in an ether or a mixture of ether as a solvent, thus forming the desired compounds.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: November 22, 2016
    Assignee: SANOFI
    Inventors: Xavier Bon, Jean-Louis Delepine, Laure Jourdin, Denis Largeau, Philippe Vayron
  • Publication number: 20150031901
    Abstract: The invention relates to a method for preparing 5-amino-benzoyl-benzofuran derivatives having the general formula in which R1 is hydrogen or an alkyl or aryl group and R2 is hydrogen, an alkyl, alkoxy or dialkylaminoalkoxy group. According to the invention, the compounds having formula I are prepared by hydrogenating a 5-nitro-benzofuran derivative having the general formula in which R1 and R2 have the same meaning as above in the presence of palladised charcoal as a catalyst and in an ether or a mixture of ether as a solvent, thus forming the desired compounds.
    Type: Application
    Filed: November 28, 2012
    Publication date: January 29, 2015
    Applicant: SANOFI
    Inventors: Xavier Bon, Jean-Louis Delepine, Laure Jourdin, Denis Largeau, Philippe Vayron
  • Patent number: 8884033
    Abstract: The disclosure relates to a process for preparing 5-aminobenzoylbenzofuran derivatives of formula I: in which R1 and R2 are as defined in the disclosure; by reduction of a 5-nitrobenzofuran derivative of formula II: using a hydrogen transfer agent, in the presence of palladium-on-charcoal as catalyst and in an ether or an ether mixture as solvent.
    Type: Grant
    Filed: January 16, 2013
    Date of Patent: November 11, 2014
    Assignee: Sanofi
    Inventors: Xavier Bon, Christine Biencourt, Corinne Leroy, Julia Mateos-Caro, Philippe Vayron
  • Patent number: 8871956
    Abstract: The invention relates to a method for preparing 3-keto-benzofurane derivatives of the general formula: Formula (I), where R is an alkyl or aryl group, R1 is hydrogen or an alkyl or aryl group, and R2 is a substituted alkyl or phenyl group. Said preparation method involves coupling a derivative of Formula III, where X is chlorine, bromine, or iodine or a sulfonate grouping: Formula (III) with a sulfonamide derivative of the formula R—SO2—NH2 in the presence of a basic agent and a catalytic system formed of a complex between a palladium compound and a ligand.
    Type: Grant
    Filed: March 30, 2011
    Date of Patent: October 28, 2014
    Assignee: Sanofi
    Inventors: Fréderic Bailly, Thomas Priem, Philippe Vayron
  • Patent number: 8796489
    Abstract: The present disclosure relates to ketobenzofuran derivatives of the general formula (I): as well as to a method of synthesizing the same by coupling a quinonimine and an enaminone by a Nenitzescu reaction and to the intermediates of the synthesis thereof.
    Type: Grant
    Filed: August 30, 2012
    Date of Patent: August 5, 2014
    Assignee: Sanofi
    Inventors: Frédéric Bailly, Bernard Grimaud, Irina Malejonock, Philippe Vayron
  • Patent number: 8748636
    Abstract: The disclosure relates to a process for preparing benzofuran derivatives of general formula I: in which R, R1, and R2 are as defined in the disclosure; by coupling the hydroxylamine with a diketone of general formula III: in order to form an oxime that is then cyclized by heating in order to form the desired compound.
    Type: Grant
    Filed: January 16, 2013
    Date of Patent: June 10, 2014
    Assignee: Sanofi
    Inventors: Frederic Bailly, Xavier Bon, Philippe Vayron
  • Patent number: 8497375
    Abstract: The invention relates to a method of synthesis of ferroquine of formula (F) or of its metabolite of formula (Fm): comprising a reaction of reductive amination, said reaction comprising: (i) a stage of condensation of an aldehyde-amino ferrocene of formula (III), in which R represents a hydrogen atom or a methyl group, with 7-chloroquinolin-4-amine as shown below, followed by (ii) a stage of reduction of the product of condensation obtained in the preceding stage and (iii) then a stage of hydrolysis of the reaction mixture in the presence of an aqueous solution of ammonia or of citric acid.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: July 30, 2013
    Assignee: Sanofi
    Inventors: Vincent Ferey, Julia Mateos-Caro, Régis Mondiere, Philippe Vayron, Sylvie Vigne
  • Publication number: 20130165673
    Abstract: The invention relates to a method for preparing 3-keto-benzofurane derivatives of the general formula: Formula (I), where R is an alkyl or aryl group, R1 is hydrogen or an alkyl or aryl group, and R2 is a substituted alkyl or phenyl group. Said preparation method involves coupling a derivative of Formula III, where X is chlorine, bromine, or iodine or a sulfonate grouping: Formula (III) with a sulfonamide derivative of the formula R—SO2—NH2 in the presence of a basic agent and a catalytic system formed of a complex between a palladium compound and a ligand.
    Type: Application
    Filed: March 30, 2011
    Publication date: June 27, 2013
    Applicant: SANOFI
    Inventors: Fréderic Bailly, Thomas Priem, Philippe Vayron
  • Publication number: 20130012729
    Abstract: The present disclosure relates to ketobenzofuran derivatives of the general formula (I): as well as to a method of synthesizing the same by coupling a quinonimine and an enaminone by a Nenitzescu reaction and to the intermediates of the synthesis thereof.
    Type: Application
    Filed: August 30, 2012
    Publication date: January 10, 2013
    Applicant: SANOFI
    Inventors: Frederic BAILLY, Bernard GRIMAUD, Irina MALEJONOCK, Philippe VAYRON
  • Patent number: 7462632
    Abstract: A process for the preparation of for the preparation of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide and of its salts, wherein 1,5-dibromopentane is reacted with a compound of formula (IIIa) in the presence of Na2CO3 in acetonitrile heated at reflux.
    Type: Grant
    Filed: November 14, 2006
    Date of Patent: December 9, 2008
    Assignee: Sanofi-Aventis
    Inventors: Philippe Vayron, Marc Daumas, Raphael Sole, Alain Dlubala
  • Publication number: 20080119653
    Abstract: A process for the preparation of for the preparation of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide and of its salts, wherein 1,5-dibromopentane is reacted with a compound of formula (IIIa) in the presence of Na2CO3 in acetonitrile heated at reflux.
    Type: Application
    Filed: November 14, 2006
    Publication date: May 22, 2008
    Applicant: SANOFI-AVENTIS
    Inventors: Philippe VAYRON, Marc DAUMAS, Raphael SOLE, Alain DLUBALA
  • Patent number: 7358371
    Abstract: The present invention comprises a process for the preparation of compounds that possess an affinity for the cannabinoid receptor in the human brain. These compounds are useful as immunomodulators and psychotropic agents in the treatment of thymic disorders, vomiting, myo-relaxation, various types of neuropathy, memory disorders, dyskinesia, migraine, asthma, epilepsy, glaucoma, anticancer chemotherapy, in ischemia and angina, in orthostatic hypotension and in cardiac distress. More specifically, the present invention comprises a process for the preparation of a series of compounds of formula (I): in which R1-R7 and W represent various alkyl groups and the derivatives thereof and are more specifically are defined herein.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: April 15, 2008
    Assignee: Sanofi-Aventis
    Inventors: Marc Daumas, Philippe Vayron
  • Publication number: 20070099978
    Abstract: The present invention comprises a process for the preparation of compounds that possess an affinity for the cannabinoid receptor in the human brain. These compounds are useful as immunomodulators and psychotropic agents in the treatment of thymic disorders, vomiting, myo-relaxation, various types of neuropathy, memory disorders, dyskinesia, migraine, asthma, epilepsy, glaucoma, anticancer chemotherapy, in ischemia and angina, in orthostatic hypotension and in cardiac distress. More specifically, the present invention comprises a process for the preparation of a series of compounds of formula (I): in which R1-R7 and W represent various alkyl groups and the derivatives thereof and are more specifically are defined herein.
    Type: Application
    Filed: October 10, 2006
    Publication date: May 3, 2007
    Applicant: SANOFI-AVENTIS
    Inventors: Marc DAUMAS, Philippe VAYRON